ORIC Earnings — Oric Pharmaceuticals, Inc. Common Stock Post-ER Performance | BigEarnings
ORIC — Oric Pharmaceuticals, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$8.45
Market Cap$874.7M
P/E—
52W Range$7.23 – $14.93
Next Earnings2026-08-11
About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
